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Introduction
============

Tuberculosis (TB) is a major public health problem in South Asia. The factors responsible for high incidence in developing countries are overcrowding, poverty, malnutrition, and poor sanitation \[[@REF1]\]. India carries the highest disease burden with reported incidence and mortality of 199 and 32.72 per 100,000 population, respectively, in 2018. The prevalence of latent TB is much higher with 40% of the entire population affected \[[@REF2]\]. The most common site of affliction is the lung, which can occur in isolation or along with other organs. The sites of extra-pulmonary disease can be lymph nodes, urogenital tract, central nervous system, abdomen, pericardium, bone marrow, eyes, skin, bones, and joints \[[@REF3]\]. Herein, a case of abdominal TB affecting the liver and spleen in the form of multiple microabscesses is presented.

Case presentation
=================

A 22-year-old male, who worked at a hardware store, presented to the outpatient department with history of fever up to 102° F with night sweats, abdominal pain, anorexia, and weight loss of 4 kg over the previous month. He had progressively increasing fatigue and had to be brought in on a wheel chair. The abdominal pain was non-colicky and present diffusely over the upper abdomen. It had no association with meals, and was not exacerbated or relieved with changes in body posture. There was no history of cough, breathlessness, hemoptysis, chest pain, headache, altered bowel habits, dysuria or rash. He did not smoke and had no health problems in the past. There was no history of any substance abuse or intake of any immunosuppressive medication.

He lived in the outskirts of the city with his parents and sister in a two-room house with poor ventilation. His parents were apparently healthy, but his sister had suffered from pulmonary TB a year earlier, for which she was treated with anti-tubercular therapy (ATT) for six months. There was no significant history of travel and they owned no pets.

On examination, he appeared dehydrated and pale with blood pressure of 110/70 mm of Hg, and pulse of 90 beats per minute with regular rhythm. There was no evidence of respiratory distress or cyanosis, and the respiratory rate was 14 breaths per minute with peripheral capillary oxygen saturation of 99%. There was no jaundice, edema or palpable lymphadenopathy. The abdominal examination revealed tender hepatomegaly, so a detailed examination was deferred. The breath sounds were vesicular in character and no added sounds were present. Cardiovascular examination did not reveal any abnormality.

The laboratory investigations revealed mild anemia, raised erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), and deranged liver functions with disproportionately elevated alkaline phosphatase (ALP) (Table [1](#TAB1){ref-type="table"}). Blood and urine cultures were sterile. Human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg) and anti-hepatitis C antibody (anti-HCV) were negative. Mantoux test was positive with an induration of 24 mm after 72 hours (Figure [1](#FIG1){ref-type="fig"}).

###### Laboratory investigations

  --------------------------------------------------------- --------------------------------------------------------------------- --------------
  Investigation                                             Value                                                                 Normal range
  Hemoglobin (g/dL)                                         10.1                                                                  13-16
  Mean corpuscular volume (fL)                              78                                                                    83-101
  Platelets (X10\^9/L)                                      180                                                                   150-400
  Total leucocyte count (X10\^9/L)                          10 (80% neutrophils, 15% lymphocytes, 3% monocytes, 2% eosinophils)   4-12
  Bilirubin (mg/dL)                                         1.3                                                                   0.2-1
  Alkaline phosphatase (U/L)                                1051                                                                  30-150
  Gamma glutamyl transferase (U/L)                          206                                                                   \<50
  Aspartate transaminase (U/L)                              227                                                                   10-40
  Alanine transaminase (U/L)                                127                                                                   10-40
  Total protein (gm/dL)                                     7.3                                                                   6-8
  Albumin (gm/dL)                                           3.2                                                                   3.5-5.5
  Globulin (gm/dL)                                          4.1                                                                   2-3.5
  Prothrombin time (seconds)                                16                                                                    14 (control)
  Sodium (mmol/L)                                           135                                                                   135-145
  Potassium (mmol/L)                                        4.1                                                                   3.5-5.5
  Urea (mg/dL)                                              53                                                                    15-40
  Creatinine (mg/dL)                                        1.3                                                                   \<1.3
  Glycosylated hemoglobin                                   5.2%                                                                   \<6%
  Erythrocyte sedimentation rate (ESR) (mm in 1^st^ hour)   72                                                                    \<10
  C-reactive protein (CRP) (mg/L)                           82                                                                    \<5
  --------------------------------------------------------- --------------------------------------------------------------------- --------------

![Positive Mantoux test\
Induration (24 mm) with a ring of erythema over the forearm, 72 hours after intradermal injection of 0.1 mL of purified protein derivative. In patients with no known risk factors for tuberculosis, induration of 15 mm or more is considered as a positive test.](cureus-0012-00000008247-i01){#FIG1}

A plain radiograph of the chest did not show any abnormality. Ultrasound of the abdomen revealed an enlarged liver (20 cm) and spleen (15 cm) with tiny hypoechoic foci. This was followed by a contrast-enhanced computed tomographic (CT) scan of the abdomen. The findings are illustrated in Figures [2](#FIG2){ref-type="fig"}-[5](#FIG5){ref-type="fig"}. 

![Axial section of contrast-enhanced CT scan of the abdomen\
Microabscesses in the liver (black arrows) and spleen (white arrow) visible as small round, hypodense lesions with minimal peripheral enhancement.](cureus-0012-00000008247-i02){#FIG2}

![Axial section of contrast-enhanced CT scan of the abdomen\
Microabscesses in the liver (black arrows) and spleen (white arrows) visible as small round, hypodense lesions with minimal peripheral enhancement.](cureus-0012-00000008247-i03){#FIG3}

![Axial section of contrast-enhanced CT scan of the abdomen\
Microabscesses in the liver (black arrows) and spleen (white arrow) visible as small round, hypodense lesions with minimal peripheral enhancement.](cureus-0012-00000008247-i04){#FIG4}

![Coronal section of contrast-enhanced CT scan of the abdomen\
Microabscesses in the liver (black arrows) visible as small round, hypodense lesions with minimal peripheral enhancement.](cureus-0012-00000008247-i05){#FIG5}

Ultrasound guided fine needle aspiration was performed from a hepatic lesion. It displayed necrotic hepatocytes within inflammatory infiltrate. Acid fast bacilli (AFB) staining did not reveal any organisms. Bodyweight based multi-drug regimen for TB was started, consisting of isoniazid 300 mg, rifampicin 600 mg, pyrazinamide 1500 mg and ethambutol 1200 mg a day. It was supplemented with pyridoxine 10 mg a day. The treatment was well tolerated, and was followed by defervescence within two weeks. His appetite increased and he started gaining weight. The culture of the hepatic aspirate did not grow tubercle bacilli at the end of six weeks. The liver function tests normalized within two months, and the liver and spleen size deceased on ultrasound with no visible parenchymal lesions.

Discussion
==========

TB can occur in virtually any abdominal structure (Table [2](#TAB2){ref-type="table"}) \[[@REF4],[@REF5]\]. The incidence of abdominal TB is estimated to be 11% of the total load of extra-pulmonary TB \[[@REF6]\]. It occurs by hematogenous or contiguous spread from other organs, or by reactivation of latent TB \[[@REF7]\]. Less commonly, ingestion of unpasteurized milk containing tubercle bacilli is implicated. Up to 25% of the patients also have pulmonary TB \[[@REF8]\]. Certain risk factors for developing abdominal TB have been identified. These include diabetes mellitus, cirrhosis, HIV infection, peritoneal dialysis, and use of anti-tumor necrosis factor (anti-TNF) drugs \[[@REF3]\].

###### Radiological and clinical features of abdominal tuberculosis

  ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------
  Structure           Radiological features                                                                                                                                            Clinical features
  Intestine           Ulcerative or hypertrophic lesions, concentric thickening of ileo-caecal region, strictures, obstruction, fistulae, lymphadenopathy, mass in right iliac fossa   Abdominal pain, fever, weight loss, diarrhea, constipation, vomiting
  Peritoneum          Peritoneal thickening, omental thickening, mesenteric thickening, ascites (with fibrotic adhesions, if longstanding), lymphadenopathy                            Abdominal distension, pain, fever, weight loss
  Liver               Miliary nodules or solitary nodule, hepatomegaly, lymphadenopathy, biliary stricture                                                                             Fever, abdominal pain, weight loss, jaundice
  Spleen (rare)       Miliary nodules, abscess, splenomegaly                                                                                                                           Fever, abdominal pain, weight loss
  Stomach (rare)      Miliary nodules, ulcers, gastric outlet obstruction                                                                                                              Fever, vomiting, dyspepsia, abdominal pain, weight loss
  Oesophagus (rare)   Mass with ulceration or stricture formation                                                                                                                      Fever, weight loss, dysphagia, dyspepsia
  Pancreas (rare)     Mass, abscess, cystic lesion, lymphadenopathy                                                                                                                    Fever, abdominal pain, weight loss, jaundice, malabsorption
  ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------

In their review of hepatic TB patients, Hickey et al. found that the most common symptoms were fever (67%), abdominal pain (59.5%), and weight loss (57.5%) \[[@REF9]\]. Concomitant respiratory symptoms were present in 66% of the cases. Elevation of alkaline phosphatase and gamma glutamyl transferase was prominent. 79% of the cases had miliary disease, consisting of widespread lesions, around 1 mm in diameter, that are seeded from the lungs hematogenously. The other 21% of the cases had local disease with larger lesions located near the portal triad, some showing calcification and peripheral enhancement on CT scan. These lesions can produce mass effect, leading to cholestatic jaundice. They concluded that 1% of all patients with active TB have liver involvement. Spleen is commonly involved in miliary TB, but its involvement in seclusion is exceedingly rare. Its involvement has also been reported in the form of an abscess, and as a contrast-enhancing mass that can mimic a neoplasm \[[@REF10],[@REF11]\].

The diagnosis is established by imaging and microscopic or molecular detection of the pathogen Mycobacterium tuberculosis. Although ultrasound and contrast barium studies may suffice in some cases, a contrast-enhanced CT scan is the ideal investigation \[[@REF7]\]. It can delineate all the lesions and the most appropriate one can be selected for tissue diagnosis. It can be obtained by radiologically guided percutaneous aspiration, endoscopy or percutaneous solid organ biopsy. Appropriate staining can reveal the AFB. Histopathology can reveal the characteristic non-caseating granulomatous inflammation, though it is not specific. Although culture can take a minimum of 2-4 weeks, it provides the opportunity for drug sensitivity testing. Nucleic acid amplification by polymerase chain reaction (PCR) can give confirmatory diagnosis within hours. Ascitic fluid is lymphocyte predominant with, in the absence of cirrhosis, low serum to ascites albumin gradient (less than 1.1 mg/dL) and adenosine deaminase (ADA) higher than 30 - 40 IU/L \[[@REF12]\]. All the aforementioned tests carry variable sensitivity and, in the event of failure to demonstrate the tubercle bacilli, the final diagnosis can still be arrived at by careful consideration of the demographics, clinical and radiologic features, exclusion of alternate diagnoses and the response to empirical treatment, as was done in the case under consideration \[[@REF7]\]. The sensitivity of AFB smears obtained from liver tissue has been found to be only 25% \[[@REF9]\]. Caseating granulomas are seen in 68% of the cases, whereas highest diagnostic sensitivity of 86% is seen with PCR \[[@REF9]\].

The general consensus on treatment is a six-month course of ATT. The initial two months comprise of the intensive phase with isoniazid, rifampicin, pyrazinamide, and ethambutol. For the remaining period, only isoniazid and rifampicin are given \[[@REF7]\]. Drug resistance is an emerging problem and it can necessitate the use of more toxic alternative drugs, and the duration of therapy is also extended. Surgery is occasionally indicated for the relief of obstruction and management of fistulae. Intestinal resection, stoma creation and stricturoplasty are the procedures usually resorted to.

Conclusions
===========

A 22-year-old male presented with a one-month history of fever, night sweats, and weight loss. He was previously healthy, but had history of contact with a TB patient. He had anemia, deranged liver functions, significantly elevated ESR, and a positive Mantoux test. CT of the abdomen revealed multiple microabscesses in the liver and spleen. There was no pulmonary disease. This report represents an atypical manifestation of TB. The patient had isolated hepatic and splenic involvement, and despite the overt clinical and radiologic manifestations, there was no histological or microbiological evidence of infection with TB. Empirical treatment with ATT was started with a successful outcome.
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